Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-09FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Procardia XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS withdrawal · 2015-01-09Clinical Trial Update: A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers [Phase 1]
Phase 1 drug interaction study of Boceprevir with amlodipine or diltiazem in healthy volunteers has been withdrawn.
-
FDA approval · 2015-01-05FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an Abbreviated New Drug Application for valsartan by Mylan Pharmaceuticals, enabling a generic version of the drug.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for valsartan, a generic ARB. The product is indicated for hypertension, heart fai…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for valsartan, a generic ARB, for hypertension, heart failure, and reducing cardiov…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Aurobindo Pharma Limited)
FDA approves the Original Application for VALSARTAN from Aurobindo Pharma Limited, enabling the generic valsartan product to enter the marke…
-
FDA approval · 2015-01-05FDA Approved: VALSARTAN — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved Jubilant Cadista Pharmacuticals Inc.'s original ANDA for valsartan, a generic angiotensin II receptor blocker. The approval ena…
-
FDA approval · 2015-01-02FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a telmisartan and amlodipine combination product by Mylan Pharmaceuticals Inc., expanding the la…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health [NA]
This update reports the completion of a clinical trial evaluating the management of hypertension and multiple cardiovascular risk factors to…
-
FDA label_change · 2014-12-31FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceuticals …
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients [Phase 4]
Phase 4 trial comparing nebivolol and metoprolol in hypertensive patients with exercise and Angiotensin II; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Denervation of the REnal Artery in Metabolic Syndrome [Phase 3]
Phase 3 trial evaluating renal denervation for metabolic syndrome has completed, assessing effects on insulin resistance and blood pressure.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial update examining free fatty acid–induced hypertension in obese subjects with type 2 diabetes. The study is completed and resul…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension [Phase 4]
A Phase 4 clinical trial at the University of Texas Southwestern Medical Center evaluated the effects of thiazide diuretics on the sympathet…
-
FDA approval · 2014-12-24FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA approved a supplemental application for ZESTORETIC, the fixed-dose combination of lisinopril and hydrochlorothiazide from Almatica P…
-
FDA approval · 2014-12-24FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) submitted by Bausch Health US, LLC.
-
FDA approval · 2014-12-24FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved a supplemental application for Enalapril Maleate by Oceanside Pharmaceuticals under NDA 018998. The approval updates the produc…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bioactive Milk Peptides and Blood Pressure [Phase 3]
A Phase 3 trial evaluating bioactive milk peptides for lowering blood pressure in Hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: A Team Model of Hypertension Care in African Americans [NA]
This clinical trial update indicates the study on a team-based hypertension care model in African Americans has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer
An update on the IMI PROTECT Work Package 2 trial investigating calcium channel blockers and cancer in hypertension. The study has completed…
-
EMA withdrawal · 2014-12-19EMA Withdrawn: Ipreziv (azilsartan medoxomil) — Takeda Pharma A/S
The EMA has withdrawn Ipreziv (azilsartan medoxomil) from the European market for hypertension.
-
FDA approval · 2014-12-19FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC under the ANDA. The action approves changes to the al…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells [Phase 4]
A Phase 4 trial evaluating Nebivolol’s effect on oxidative stress and endothelial progenitor cells in hypertension; results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension [Phase 4]
A Phase 4 trial evaluated Nebivolol for improving endothelial dysfunction in African Americans with hypertension; results were posted in Dec…